| [1] |
中华人民共和国国家卫生健康委员会, 中华人民共和国国家发展和改革委员会, 中华人民共和国教育部, 等. 关于印发遏制结核病行动计划(2019—2022年)的通知. 国卫疾控发〔2019〕41号. 2019-05-31.
|
| [2] |
中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发中国结核病预防控制工作技术规范(2020年版)的通知. 国卫办疾控函〔2020〕279号. 2020-04-02.
|
| [3] |
中华人民共和国国家卫生和计划生育委员会办公厅, 中华人民共和国教育部办公厅. 关于印发学校结核病防控工作规范(2017版)的通知. 国卫办疾控发〔2017〕22号. 2017-06-26.
|
| [4] |
中华人民共和国国家卫生健康委员会办公厅, 中华人民共和国教育部办公厅. 关于印发中国学校结核病防控指南的通知. 国卫办疾控函〔2020〕910号. 2020-10-16.
|
| [5] |
World Health Organization. WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: Module 1: prevention. Geneva:World Health Organization, 2020.
|
| [6] |
World Health Organization. Global tuberculosis report 2020. Geneva: World Health Organization, 2020.
|
| [7] |
World Health Organization. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: World Health Organization, 2015.
|
| [8] |
中华人民共和国国家卫生和计划生育委员会办公厅. 国家卫生计生委办公厅关于调整艾滋病免费抗病毒治疗标准的通知. 国卫办医函〔2016〕618号. 2016-06-08.
|
| [9] |
INSIGHT START Study Group, Lundgren JD, Babiker AG, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med, 2015,373(9):795-807. doi: 10.1056/NEJMoa1506816.
doi: 10.1056/NEJMoa1506816
URL
pmid: 26192873
|
| [10] |
Government of Canada. Canadian Tuberculosis Standards 7th Edition: 2014[EB/OL]. [2021-01-29]. https://www.canada.ca/en/public-health/services/infectious-diseases/canadian-tuberculosis-standards-7th-edition.html.
|
| [11] |
Centers for Disease Control and Prevention. Latent Tuberculosis Infection: A Guide for Primary Health Care Providers[EB/OL].[2021-01-29]. https://www.cdc.gov/tb/publications/ltbi/.
|
| [12] |
Gao L, Li X, Liu J, et al. Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis, 2017,17(10):1053-1061. doi: 10.1016/S1473-3099(17)30402-4.
doi: 10.1016/S1473-3099(17)30402-4
URL
pmid: 28716677
|
| [13] |
Eakle R, Venter F, Rees H. Pre-exposure prophylaxis (PrEP) in an era of stalled HIV prevention: Can it change the game? Retrovirology, 2018,15(1):29. doi: 10.1186/s12977-018-0408-3.
doi: 10.1186/s12977-018-0408-3
URL
pmid: 29609619
|
| [14] |
Getahun H, Matteelli A, Chaisson RE, et al. Latent Mycobacterium tuberculosis infection. N Engl J Med, 2015,372(22):2127-2135. doi: 10.1056/NEJMra1405427.
doi: 10.1056/NEJMra1405427
URL
pmid: 26017823
|
| [15] |
Saunders MJ, Wingfield T, Datta S, et al. A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study. Lancet Infect Dis, 2020,20(1):110-122. doi: 10.1016/S1473-3099(19)30423-2.
doi: 10.1016/S1473-3099(19)30423-2
URL
pmid: 31678031
|
| [16] |
Stanford J, Stanford C, Grange J. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis. Front Biosci, 2004,9:1701-1719. doi: 10.2741/1292.
doi: 10.2741/1292
URL
pmid: 14977580
|
| [17] |
World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
|
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
